ACORDA THERAPEUTICS INC (ACOR) Stock Analyst Ratings
NASDAQ:ACOR - Nasdaq - US00484M7002 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to ACOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 1443.12% above the current price.
ACOR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACOR.
In the previous month the buy percentage consensus was at a similar level.
ACOR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-06-17 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |